TMC207 +/- Rifabutin/Rifampin

NCT01341184 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifabutin
DRUG: Rifampin
DRUG: TMC207

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)